The global metagenomics market size was estimated to be US$ 565 million in 2020 and is expected to reach US$ 1.8 billion by 2031 at a CAGR of 11.2%.
Metagenomics alludes to the investigation of microbial genomes in the regular habitat. It includes cloning of the genome to examine the environment, advancement and variety, subsequently bypassing the requirement for separation and research center development of individual species.
Metagenomics utilizes sequencing and bioinformatics advancements to get logical experiences and is used as an atomic device for examining the deoxyribonucleic acid that is DNA procured from the natural habitat samples, namely, through water source, soil source and human waste. Metagenomics is a moderately new field, which includes the assessment of aggregate genomes of the microbial species, alongside the inspecting of organism interface.
It is one of the utilizations of ongoing genomics techniques to the investigation of groups of microorganisms straightforwardly in their standard surroundings, by staying away from the requirement. Quick head ways in genomic techniques and subordinate conventions have empowered the investigation of microbial consortia inside the host as a joined substance. This is postulated to hold huge market potential in discrete life sciences businesses.
Presentation of high-throughput sequencing procedures namely, iSeq 100 Framework, MiniSeq Framework, and NextSeq 550 Framework for amplicon sequencing has worked with phylogeny and scientific classification investigations of assorted metagenomics tests. Bioinformatics organizations assume a huge part in the development of metagenomic labs, as they assist with supporting their work processes.
For example, in December 2018, QIAGEN dispatched metagenomic modules for examination in a joint effort with CosmosID. Besides, Once more get together, entire genome sequencing, shotgun metagenomics, and 16S rRNA sequencing permit worked on investigation.
This increment in directing of sequencing advancements can be credited to declining cost lately. Moreover, work driven innovation permits ID of proteins engaged with debasement of toxins and forecast of corruption rates. For example, it has been utilized in understanding the in situ biodegradation instrument of organophosphorus compounds and to foresee its corruption potential.
The sequencing-driven segment represented the biggest income share in the metagenomics market in 2019 attributable to higher execution of this innovation. High reception of this innovation can be ascribed to coming of novel bioinformatics-related arrangements, which improves on work processes and gives fast outcomes.
It utilizes bioinformatics devices and computational investigation like CoMet, MEGAN, METAREP, CAMERA, and IMG/M to convey quick outcomes. Moreover, endeavors to keep a standard data set and ascend in number of metagenome test stored at information vaults are expected to drive the succession driven strategy segment.
Furthermore, metagenomics makes it conceivable to research assets for the improvement of catalysts, novel genes, and synthetic mixtures for use in biotechnology. Besides, an extensive development of metagenomic applications throughout the years has additionally intensified the market evolution. Subsequently, driving the interest and expanding the uses of the metagenomics market during 2023-2032.
North America was seen overwhelming the market as far as income in 2019 is concerned. This can be credited to the presence of a significant number of noticeable biotechnology organizations, the greater part of which are centered around improvement of metagenomics work processes. For example, in May 2015, CosmosID presented its Virtuoso Metagenomics application accessible in Illumina's BaseSpace Applications for use with NGS stages. Asia Pacific is relied upon to observe the quickest improvement during the forecast time frame of 2023-2032, resulting from steady improvements embraced to fortify the bioinformatics framework and genomic scene in nations like India and China.
Global Metagenomics Market Value Share Analysis, by Geography (2022)
The report titled “Global Metagenomics Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is the historic period, 2022 is the base year, and 2023 to 2032 is the forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Metagenomics Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Metagenomics market is segmented as products, technology, application, and region. Based on product, the Metagenomics market is segmented into Kits & Reagents, Sequencing, Data Analytics Services, Others. Based on technology, the Metagenomics market is segmented into Sequencing Driven, Function Driven, Others. Based on application Channel, the Metagenomics market is segmented into Vitamins, Environmental, Human Health, Other. Based on geography, the Global Metagenomics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Metagenomics Market. Further, market share of prominent companies in the Global Metagenomics Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Metagenomics companies. The Global Metagenomics Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Metagenomics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Metagenomics Market.
The key players of the Global Metagenomics Market are Illumina. Inc., Novogene Corporation, Promega Corporation, Oxford Gene Technology, Inc., TAKARA BIO INC., Danaher, Thermo Fisher Scientific, Inc., QIAGEN, ELITechGroup, and others
Global Metagenomics Market Key Segments:
Based on Product
Based on Technology
Based on Application
By Region
The global metagenomics market is expected to reach US$ 1.8 billion by 2031.
The global metagenomics market is expected to register a CAGR of 11.2% through 2031.
Illumina. Inc., Novogene Corporation, Promega Corporation, Oxford Gene Technology, Inc., TAKARA BIO INC. are few prominent players active in the market.
The major applications of Metagenomics include Vitamins, Environmental and Human Health.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved